Quick Answer
ClearPoint Neuro, Inc. reported Gross Profit of $22.69 million for the year ending 2025.
- ClearPoint Neuro, Inc. showed an increase of +18.7% in Gross Profit from 2024 to 2025.
- This data is from ClearPoint Neuro, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $1.68 million | Q3 2020: $2.62 million | Q1 2021: $2.61 million | Q2 2021: $2.27 million | Q3 2021: $3.04 million | Q1 2022: $3.23 million | Q2 2022: $3.26 million | Q3 2022: $3.68 million | Q1 2023: $3.20 million | Q2 2023: $3.13 million | Q3 2023: $3.27 million | Q1 2024: $4.53 million | Q2 2024: $4.99 million | Q3 2024: $4.85 million | Q1 2025: $5.13 million | Q2 2025: $5.56 million | Q3 2025: $5.60 million.
- Over the full 6 years of available data (2020 to 2025), ClearPoint Neuro, Inc.'s Gross Profit has grown by 148.8%.
- Historical annual values: Fiscal year 2025: $22.69 million | Fiscal year 2024: $19.12 million | Fiscal year 2023: $13.61 million | Fiscal year 2022: $13.53 million | Fiscal year 2021: $11.12 million | Fiscal year 2020: $9.12 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: